Evaluation of Subcutaneous Phenobarbital Administration in Hospice Patients

This study evaluates the tolerability of phenobarbital administered subcutaneously. Of 69 patients and 774 distinct subcutaneous phenobarbital injections, 2 site reactions were recorded (2.9% of patients; 0.3% of injections). Both were mild, grade 1 reactions. Each patient continued to receive subcutaneous phenobarbital via newly placed ports with no additional reactions. Based on these findings, phenobarbital appears to be well tolerated when administered subcutaneously.

Source: American Journal of Hospice and Palliative Medicine - February 17, 2016 Category: Palliative Care Authors: Hosgood, J. R., Kimbrel, J. M., Protus, B. M., Grauer, P. A. Tags: Original Articles Source Type: research